Aim: Carotid intima-media thickness (IMT) is a useful surrogate marker of cardiovascular disease and is associated with cardiac events. We investigated cross-sectionally the association between carotid intima-media thickness (IMT), confounding risk factors, and metabolic syndrome (MetS) using the modified Japanese criteria. 
Introduction
Metabolic syndrome (MetS) is defined as the clustering of several cardiovascular risk factors in an individual, including visceral obesity, hypertension (HT), a high level of triglycerides (TG), a low level of highdensity-lipoprotein cholesterol (HDL-C), and impair-, and that it is a predictor of coronary heart disease, stroke, and type 2 diabetes 5, 6) . Alexander et al. 7) have reported that MetS with diabetes is associated with the highest prevalence of coronary heart disease compared with MetS without diabetes and diabetes without MetS in participants 50 years of age. Moreover, Iglseder et al. 8) have demonstrated that the effect of MetS on early atherosclerosis is more pronounced in women than in men because of the strong link between MetS and type 2 diabetes.
Carotid intima-media thickness (IMT) can now be measured noninvasively by B-mode ultrasonography and is an important surrogate marker of cardiovascular disease. Growing evidence has shown close associations between this parameter and conventional cardiovascular risk factors [including age, obesity, smoking status, HT, dyslipidemia including decreased HDL-C and increased low-density-lipoprotein cholesterol (LDL-C)], uric acid level, and diabetes [9] [10] [11] , but to our knowledge there have been few published reports assessing the relation of MetS and diabetes to carotid IMT among older men and women without subclinical atherosclerosis.
In the present study, we examined cross-sectionally the prevalence of carotid atherosclerosis among persons with MetS but without diabetes, with diabetes, and with neither condition.
Materials and Methods

Subjects
Participants were consecutively enrolled from among inpatients in the medical department of Seiyo Municipal Nomura Hospital between August 1996 and April 2006. Patients with a clinical history of cerebrovascular disease, neurological abnormalities, or cerebral hemorrhage were excluded. Informed consent for the procedure was obtained from each patient. All procedures were approved by the Ethics Committee of Seiyo Municipal Nomura Hospital.
Evaluation of Risk Factors
We measured blood pressure (BP) in the right upper arm of patients in a sedentary posture using a standard sphygmomanometer or an automatic oscillometric blood pressure recorder. Height and weight, used to calculate body mass index (BMI) as weight in kilograms divided by the square of height in meters, were measured by standard procedures. Cigarette smoking was quantified based on daily consumption and duration of smoking. For blood biochemistry analyses, total cholesterol (TC), TG, HDL-C, uric acid, and blood glucose (BG) were measured under a fasting condition within 24 hours of admission. The level of LDL-C was calculated by the Friedewald formula 12) , and those with TG levels 400 mg/dL were excluded. The history of antihypertensive and/or antilipidemic drug use was also evaluated. The presence or absence of diabetes was diagnosed at the first examination using a 75-g oral glucose tolerance test. Patients who had been treated for type 2 diabetes were defined as diabetic.
Ultrasound Image Analysis
An ultrasonograph (Hitachi EUB-565 or Aloka SSD-2000) equipped with a 7.5-MHz linear type Bmode probe was used by a specialist in ultrasonography to evaluate sclerotic lesions of common carotid arteries on a day close to the day of blood biochemistry analysis (within two days). Patients were asked to assume a supine position, and bilateral carotid arteries were observed obliquely from anterior and posterior directions. We measured the thickness of the intima-media complex (IMT) on the far wall of the bilateral common carotid artery about 10 mm proximal to the bifurcation of the carotid artery (as the image at that site is more clearly depicted than that at the near wall) 13, 14) as well as wall thickness near the 10-mm point on the B-mode monitor. We then used the mean value for analysis. To evaluate differences in IMT measurement by the ultrasonography machines, one investigator (R.K.) repeated the scans of each machine with a one-month interval in a random subsample (n 9). Cronbach of reliability coefficients was 0.91.
Regarding the measurement of fat thickness by ultrasonographic evaluation (Hitachi EUB-565 or Aloka SSD-2000) using a 7.5-MHz linear-type B-mode probe, the subjects were placed in a supine position, the probe was held perpendicular to the skin at the epigastrium, and vertical scanning was performed along the abdominal median from the processus xiphoideus to the umbilicus to measure the maximal thickness of preperitoneal fat (Pmax) at the anterior surface of the liver 15) .
Metabolic Syndrome
We applied condition-specific cutoff points for MetS based on modified guidelines for the diagnosis of MetS in Japan 16, 17) . MetS was defined as visceral obesity assessed by ultrasonography and at least two of the following three conditions: HT, dyslipidemia and impaired fasting glucose.
• Visceral obesity was indicated by Pmax 6.9 mm in men or 10 mm in women (equal to visceral fat accumulation 100 cm 2 as measured by computed tomography) 18) .
• Hypertension was defined as systolic blood pressure (SBP) 130 mmHg or diastolic blood pressure (DBP) 85 mmHg or those who had been treated for hypertension. • Dyslipidemia was identified by an HDL-C 40 mg/ dL or TG concentrations 150 mg/dL or a history of previous treatment for dyslipidemia.
• Impaired BG was defined as fasting plasma glucose 110 mg/dL or a history of previous treatment for diabetes.
Statistical Analysis
All values are expressed as the mean standard deviation (SD), unless otherwise specified. Statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). Prevalence among control subjects and MetS patients was compared by the 2 test. Differences among groups were analyzed by the Mann-Whitney U-test or Kruskal-Wallis test. A multiple regression model was employed to evaluate the significance of confounding risk factors and MetS for carotid IMT. The relation between carotid atherosclerosis (IMT 1.0 mm) 14) and risk factors was examined by logistic multiple regression analysis. A value of p 0.05 was considered significant. Table 1 shows the clinical characteristics of the 918 subjects categorized by diabetes and MetS. Among our 918 patients (394 men aged 66 15 years and 524 women aged 72 13 years), 74 (8.1%) had no metabolic abnormalities (neither condition), 478 (52.1%) had a metabolic abnormality with neither diabetes or MetS, and 366 (47.9%) had diabetes and/or MetS. Among these latter 366 patients, 239 had diabetes, including 107 (11.7%) patients with both diabetes and MetS, and another 132 (14.4%) diabetic patients did not MetS. Comparison of these latter four groups demonstrated that the MetS and diabetic groups showed a greater prevalence of males, antihypertensive drug use, and antilipidemic drug use as well as higher BMI, smoking status, BP, TC, TG, LDL-C and fasting plasma glucose than patients without metabolic abnormalities. For most cardiovascular risk factors, the group with MetS and without diabetes showed a distribution comparable to that in diabetes with MetS but not to either of the groups without MetS.
Results
Background of Subjects by Metabolic Conditions
Criteria for Metabolic Syndrome Among Subjects by Metabolic Conditions
The prevalence of each group meeting each Japanese criterion for MetS is shown in Table 2 . Again, the prevalence of characteristics in the two MetS groups was comparable, with the exception of impaired fasting glucose, but it differed from that in the two groups without MetS.
Distribution of Carotid Atherosclerosis by Metabolic Conditions
Carotid IMT values in the four groups with any metabolic abnormalities were significantly greater than the IMT of the group with neither condition, respec- The values are the means standard deviation. Body mass index was calculated using weight in kilograms divided by the square of the height in meters. Smoking status: daily consumption (pack) duration of smoking (year). Kruskal-Wallis test or tively ( Table 3) . Moreover, the carotid IMT of patients with both MetS and diabetes was significantly greater than that of those without these conditions (p 0.032). The prevalence of carotid IMT 1.0 mm also showed a stepwise increase in relation to the prevalence of metabolic abnormalities (p 0.002). Fig. 1 shows multivariate-adjusted carotid IMT in subjects categorized by the presence of MetS and diabetes. Individuals with neither metabolic condition had the smallest carotid IMT, and individuals with MetS in the presence of diabetes had greatest. Differences between the groups were significant (p 0.001).
Adjusted Carotid Intima-Media Thickness in Subjects by Metabolic Conditions
Odds Ratio of Carotid Atherosclerosis Associated with Metabolic Syndrome
Using the 2 test, we also analyzed the risk of carotid atherosclerosis in relation to the presence of metabolic syndrome and different component conditions of the syndrome ( Table 4) . In the syndrome model, 
Odds Ratio of Carotid Atherosclerosis (Carotid IMT 1.0mm) Associated with Metabolic Syndrome
Multiple logistic regression analysis for carotid atherosclerosis was performed using age ( 75 years), male sex, smoking status ( 40 pack-years), elevated LDL-C ( 130 mg/dL) as variables by metabolic conditions in these subjects ( showed a higher odds ratio after adjustment for covariates.
Then, we assessed the association between each metabolic condition and carotid atherosclerosis among strata of these independent risk factors ( Table 5 ). In Adjusted for aging ( 75 years), sex, smoking status ( 40 packyears), and elevated LDL cholesterol ( 130 mg/dL). the multivariate models, the four groups with any metabolic abnormalities were more strongly associated with the presence of carotid atherosclerosis than neither condition in terms of age ( 75 years), female sex and smoking status ( 40 pack-years), while p values for interactions were not significant in any stratum among subgroups.
Discussion
Our findings indicate that the presence of MetS and/or type 2 diabetes increases the likelihood of early carotid atherosclerosis as assessed by ultrasonography, and the odds of early carotid atherosclerosis among patients with both MetS and type 2 diabetes was fivefold higher than among patients without any metabolic abnormalities. In our study, MetS was present in 34.5% of men and 18.7% of women, and diabetes was found in 26.4% of men and 25.8% of women. Importantly, MetS and type 2 diabetes were associated with independently increased risk factors for carotid IMT after taking risk factors into account. Furthermore, MetS and type 2 diabetes seem to play a role in accelerating this age-associated process.
In the present study, we tentatively defined MetS using modified guidelines for the diagnosis of MetS in Japan 16) ; therefore, the estimation of visceral fat accumulation is an important step in evaluating insulin resistance and multiple risk factors for cardiovascular disease. The alternative of computed tomography (CT) scanning provides a better estimation as a standard method 16) , but exposure to ionizing radiation, high cost, a time-consuming procedure, and technical difficulties prevent the wide use of CT in clinical and epidemiologic studies. Because of these limitations, alternative, simple, noninvasive methods of assessing regional adiposity are needed. The use of waist circumference 16) and visceral fat thickness by ultrasonography 15, [18] [19] [20] [21] as predictors of cardiovascular risk factors has been reported. In this study, we used Pmax measured by ultrasonography as the cutoff point of visceral obesity because some studies have reported that Pmax had a close relationship to visceral fat accumulation evaluated by CT scanning 15, 18) and serum insulin level 20, 21) . We assessed the separate relationships of MetS and type 2 diabetes to the likelihood of carotid atherosclerosis. The prevalence of MetS also increases with increasing glucose intolerance 22) , and in our study, MetS was higher among those with versus those without diabetes, although MetS is also a predictor of type 2 diabetes 5, 6) . One possible reason for the association between MetS and type 2 diabetes is the direct effect of insulin resistance on these metabolic abnormalities 23, 24) . Moreover, new data suggest that hyperleptinemia rather than hyperinsulinemia may play an im- . It has been thought that the excess prevalence of carotid atherosclerosis seen in patients with diabetes is directly associated with hyperglycemia 26, 27) and that the prevalence of carotid atherosclerosis seen in those with MetS is associated with a wide spectrum of risk factors for atherosclerosis 11) . In fact, both MetS and type 2 diabetes are characterized by hyperinsulinemia (insulin resistance), leading to an increased risk of atherosclerotic cardiovascular diseases. In hyperinsulinemic subjects, a trend toward increasing IMT values was observed according to the stages of glucose intolerance. Early and asymptomatic signs of carotid atherosclerosis could be detected in subjects who showed hyperinsulinemia on screening 28) ; however, it is unclear whether MetS and type 2 diabetes confer an elevated risk beyond the sum of their components. MetS has recently been recognized as a predictor of atherosclerosis and cardiovascular disease. As a result, it should be elucidated whether MetS must be involved in the evaluation of atherosclerotic risk, because type 2 diabetes is involved in impaired fasting glucose as a component of MetS 29) . Multivariate analysis would suggest that the risk from MetS is derived from its individual components, especially HT and dyslipidemia. The prevalence of MetS or type 2 diabetes provides an additional and strong independent effect on carotid IMT for the prediction of inducible atherosclerosis. Moreover, the presence of metabolic abnormalities was associated with increased odds of inducible carotid atherosclerosis even after adjusting for age, sex, smoking status, and LDL-C. In addition, carotid IMT increases with increasing numbers of MetS components 11, 30) , thus supporting the notion that the components of MetS may be most potent when presented in combination, as has been shown for the prediction of carotid atherosclerosis 11) . In this study, the prevalence of carotid atherosclerosis among all subjects with both MetS and type 2 diabetes was increased compared with its prevalence among those with either MetS or type 2 diabetes. Subjects without MetS but with type 2 diabetes had about the same prevalence of carotid atherosclerosis as those with MetS without type 2 diabetes. In fact, it is reported that the combination of MetS and diabetes markedly increases the risk of cardiovascular events 31) . Our study had a number of important limitations in the interpretation of results. In the present study, we had to evaluate the differences in cartoid IMT between two different machines; however, these machines provided high reproducibility with Cronbach 0.9. Moreover, based on our cross-sectional study design, the results are inherently limited in their ability to eliminate causal relationships between risk factors and carotid atherosclerosis. Since all participants were hospitalized patients, we could not eliminate the possible effects of underlying diseases on IMT findings. We also could not eliminate the possible effect of medication for HT, low HDL-C, and elevated LDL-C on our findings. Secondary prevention interventions for obesity, HT, low HDL-C, and type 2 diabetes may be successful in reducing risk factors, thus attenuating the observed association of risk factors with disease. These issues need to be addressed again using a large population-based sample in a prospective fashion.
In summary, we reported a significant association between the clustering of cardiovascular risk factors called MetS and type 2 diabetes on carotid IMT in subjects with risk factors for atherosclerosis. Furthermore, MetS and type 2 diabetes as well as age, smoking status, and LDL-C were significantly associated with carotid atherosclerosis. This syndrome confers an increased risk of cardiovascular morbidity, and its identification may thus be important in risk assessment and the treatment of patients.
